Overall, these results indicated that anti-PD-1 mAb could suppress tumor angiogenesis, growth, invasion, and metastasis, and may interfere with gene transcription by inhibiting acetylation and regulating the expression of other IC/IC ligand expression. This evidence concerns the gene PDCD1 and neoplasm.